Mariana Mihalusova focuses on biotech and pharmaceutical investments. Mariana brings to Venrock deep experience spanning the entire spectrum of drug development – from preclinical, to marketing approval, to lifecycle management. Prior to joining Venrock, Mariana was an executive at Celgene Corporation (Research & Early Development), where she led the global development strategies for over a dozen drugs across a diverse set of disease areas (hematology, oncology, inflammation/immunology, neurodegenerative diseases) and modalities (small molecules, biologics, engineered cell therapies).
Mariana received her Ph.D. in Biochemistry from Harvard University, MBA from Harvard Business School, and Sc.B. in Biochemistry from Brown University.